A Safety and Immunogenicity Evaluation of a Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) and a Meningococcal Polysaccharide Vaccine Groups A, C, Y, and W-135 Combined (Menomune - A/C/Y/W-135) in Subjects 56 Years of Age or Older.

Trial Profile

A Safety and Immunogenicity Evaluation of a Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) and a Meningococcal Polysaccharide Vaccine Groups A, C, Y, and W-135 Combined (Menomune - A/C/Y/W-135) in Subjects 56 Years of Age or Older.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 19 Jun 2013

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Meningococcal vaccine groups A C Y W-135 polysaccharide (Primary)
  • Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections; Meningococcal infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 22 Jun 2012 Additional trial identifier (U1111-1115-6685) identified as reported by ClinicalTrials.gov.(Extension trial; NCT01239043).
    • 22 Jun 2012 Additional trial identifier (U1111-1115-6685) identified as reported by ClinicalTrials.gov.(Extension trial; NCT01239043).
    • 02 Apr 2012 Actual patient number is 129 as reported by ClinicalTrials.gov (Extension trial; NCT01239043).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top